If approved, Cabometyx® would be the first and only systemic therapy approved in the European Union for previously treated neuroendocrine tumors, regardless of tumor site, grade or previous non-somato ...

Bank of America Securities analyst Jason Zemansky downgraded Keros Therapeutics, Inc. (NASDAQ:KROS) from Buy to Neutral, ...

Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL) Q3 2025 Earnings Conference Call June 5, 2025 11:00 AM ETCompany ParticipantsAdam Hanan - Manager of ...

LONDON, UK - Media OutReach Newswire - 5 June 2025 - Takeda, a global value-based, R&D-driven biopharmaceutical company, has been proudly recognized as one of the Top 10 Best Places to Work in the ...

LONDON, UK – Media OutReach Newswire – 5 June 2025 – Takeda, a global value-based, R&D-driven biopharmaceutical company, has been proudly recognized as one of the Top 10 Best Places to Work in the ...

ELKHART, Ind. (AP) — ELKHART, Ind. (AP) — Thor Industries Inc. (THO) on Wednesday reported fiscal third-quarter earnings of $135.2 million. On a per-share basis… ...

Takeda has received approval from the European Commission (EC) for its Pfizer-partnered blood cancer drug Adcetris (brentuximab vedotin). The drug has been approved in combination with the ...

British retailer WH Smith on Wednesday reported a 5% rise in total like-for-like revenue for the third quarter, with North America up 2%, driven by travel demand that lifted sales across its ...

The European Commission (EC) has granted approval for Takeda's antibody-drug conjugate (ADC) Adcetris (brentuximab vedotin). Skip to site menu Skip to page content. PT. ... Private equity deals in ...

Next on the most anticipated Xbox games releasing in Q3 2025 is Hell is Us. Quite some bone-chilling scenes in the trailer, exploring Hadea. But it has an intriguing story, too, with lots of haunting ...

US drugmaker Protagonist Therapeutics (Nasdaq: PTGX) and Japan’s Takeda Pharma (TYO:4502) announced detailed results from the Phase III, randomized, placebo-controlled VERIFY study evaluating ...

Takeda Investor Conference Call and Webcast Details. Takeda will host an investor call regarding this update on Sunday, June 1, 6-6:45 pm CDT/ 7-7:45 pm EDT / Monday, June 2, 08:00-08:45 (JST). The ...